Remove 2025 Remove Pharmaceutical Companies Remove Pharmaceutical Manufacturing
article thumbnail

CDMO Live 2025 to spotlight the future of pharmaceutical outsourcing in Europe

Express Pharma

CDMO Live is set to take place on 7-8 May 2025 at Rotterdam’s World Trade Center, bringing together key decision-makers in pharmaceutical outsourcing. The demand for outsourcing in pharmaceutical manufacturing has grown significantly, with nine out of ten biotechnology companies now depending on contract partners for production.

article thumbnail

STAT+: Pharmalittle: We’re reading about senators probing telehealth, Boston’s slumping biotech hub and more

STAT

senators sent letters to five telehealth companies that offer care through direct-to-consumer portals from pharmaceutical manufacturers Pfizer and Eli Lilly, interrogating their financial relationships , STAT tells us. Telehealth companies that prescribe a range of medications have not been held to the same standards. 

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

PHARMEXCIL strengthens India-UAE partnership

Express Pharma

The Pharmaceutical Export Promotion Council of India (PHARMEXCIL) announces its renewed commitment to strengthening the strategic partnership between India and the United Arab Emirates (UAE) in the pharmaceutical sector.

article thumbnail

EU Urban Wastewater Treatment Directive may compromise EU medicine availability

European Pharmaceutical Review

Based on the new cost estimates, pharmaceutical manufacturers in Finland alone will be required to fund 280816 million of these expenses, The directive , enforced on 1 January 2025, imposes an extended manufacturer responsibility on the removal of micro-pollutants from wastewaters.

article thumbnail

AI-driven drug discovery, precision medicine, and sustainable manufacturing can redefine the pharma industry

Express Pharma

What are the top 3 trends that defined pharma manufacturing in India and globally in 2024? In 2024, the pharmaceutical manufacturing landscape underwent transformative changes, driven by technological innovations, regulatory adaptations, and evolving global demands.

article thumbnail

Innovative radioligand manufacturing facility inaugurated

European Pharmaceutical Review

The first industrial-scale pharmaceutical manufacturing facility for production of lead-212-based radioligand therapies has been inaugurated. The company hopes to produce this number tenfold by the end of 2030. billion.

article thumbnail

Pharmacy benefit management demystified: How PBMs influence prescription drug pricing

HealthPartners

They may keep or pass through a percentage of prescription drug rebates paid by pharmaceutical companies in return for placing their drugs on the plan’s formulary (list of preferred drugs). Other drug sales-related incentive payments from drug manufacturers to the PBM may not be disclosed or passed through. billion by 2025.